With a prioritisation on the co let ion of the new chip...

With a prioritisation on the co let ion of the new chip development with realtec

so the gen 4 in production , the one with feedback- the one at ces but not marketed except under a confidentiality agreement- shssssh

Sorta explains why the application for fda isn’t in, if the single chip for gen4 isn’t completed

anyhooooo- nuhera trying to sell itself
Admitting the pivot means less sales and th expansion to all these pow was as expected a flop

looks like more nice heavy dilution but with exciting attached options

a change that will require more internal capabilities—- mmmm more salaries ?

The options are free yes but you have to pay if they spike it- and why would nuh go up nearly 100 percent within 90 days other than absurd exciting announcements

if she spikes at all- some will limit their losses

the only value really as I’ve said before is the accumulated extreme tax losses